Sign in
Explore the registryTrack Enlicitide decanoate's trials

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

Enlicitide DecanoateOngoingActive not recruitingPhase 3Open NCT06008756 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…